|
|
(June 14, 2024) – The KHA's Heart of Health Care Worker Award highlights hospital employees who have made a significant contribution to the betterment of their hospital. This week, KHA honors Becky Levin, Phillips County Health Systems, Phillipsburg, for her service and contributions to health care.
|
|
|
|
(June 14, 2024) – The KHA Advocacy All-Star Training has been established to help hospitals develop internal leaders who can effectively and comfortably advocate on behalf of your hospital.
|
|
|
|
(June 14, 2024) – The KHA's Heart of Health Care Worker Award highlights hospital employees who have made a significant contribution to the betterment of their hospital. This week, KHA honors Bridget Brion, AdventHealth South Overland Park, for her service and contributions to health care.
|
|
|
|
(July 3, 2024) – This webinar will focus on how staff can best implement de-escalation techniques, review core CPI principles and techniques and review patient care scenarios.
|
|
|
|
(June 14, 2024) – The 2024 Benefits Survey Report is now available to hospitals that participated in the 2024 survey.
|
|
|
|
(June 14, 2024) – The Kansas Medical Assistance Program has issued bulletin 24105 regarding the rate increase for Community Health Worker services effective with dates of service on and after July 1, 2024.
|
|
|
|
(July 19, 2024) – Now in its 15th year, the Summit on Quality is a day full of learning, networking and innovation designed to engage and connect a wide range of health care professionals practicing in urban and rural settings.
|
|
|
|
(June 28, 2024) – Carlos Schwindt and Dr. Nicole Freund from the KU School of Medicine in Wichita are conducting a study about the perceptions of rural Kansas hospital leadership in accountable care organizations.
|
|
|
|
(June 14, 2024) – Experts from the CDC will discuss the clinical features of influenza A(H5N1), recommendations and considerations for influenza testing and treatment, and strategies for culturally competent patient evaluations for possible exposure to influenza A(H5N1).
|
|
|
|
(June 14, 2024) – The FDA advised manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines for use in the U.S., beginning in fall 2024, should be monovalent JN.1 vaccines to more closely match currently circulating SARS-CoV-2 viruses.
|
|
|